AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32040891 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 75
Study 35854659 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercises
Number of subjects: 30
Study 35854659 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercises
Number of subjects: 30
Study 33577618 — intervention group
Group type: EXPERIMENTAL
Intervention: Adachi Rehabilitation Programme (ARP)
Number of subjects: 96
Study 33577618 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 96
Study 35590291 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat mini‐program 'Clean Teeth' based on HAPA theory + care as usual
Number of subjects: 44
Study 35590291 — intervention group
Group type: COMPARATOR
Intervention: Routine oral health education (Control)
Number of subjects: 44
Study 34044562 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (TXB2, 6‐k‐PGFla, BG levels)
Number of subjects: 216
Study 34044562 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal levels of TXB2, 6‐k‐PGFla, BG)
Number of subjects: 216
Study 34044562 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined detection of TXB2, 6‐k‐PGFla, and BG
Number of subjects: 216
Study 32618134 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg tablets for 24 weeks
Number of subjects: 90
Study 32618134 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 24 weeks
Number of subjects: 90
Study 36266431 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin 140 mg administered twice daily for 12 weeks
Number of subjects: 70
Study 36266431 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 33782049 — intervention group
Group type: EXPERIMENTAL
Intervention: Netazepide
Number of subjects: 20
Study 33782049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 36378543 — intervention group
Group type: EXPERIMENTAL
Intervention: IMT + CR
Number of subjects: 96
Study 36378543 — intervention group
Group type: COMPARATOR
Intervention: CR
Number of subjects: 96
Study 33121884 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain bupivacaine (10.9 mg of intrathecal 0.5% plain bupivacaine with 0.2 mg morphine)
Number of subjects: 168
Study 33121884 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine (10.9 mg of intrathecal 0.5% hyperbaric bupivacaine with 0.2 mg morphine)
Number of subjects: 168
Study 33121884 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain bupivacaine
Number of subjects: 168
Study 33121884 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine
Number of subjects: 168
Study 32993573 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus Nerve Stimulation (VNS) Therapy
Number of subjects: 500
Study 36342678 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 483
Study 36342678 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 483
Study 36342678 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Tailored Print Feedback (CTPF)
Number of subjects: 483
Study 36342678 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 483
Study 33799302 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 3077
Study 33799302 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous alteplase
Number of subjects: 3077
Study 33799302 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent retrievers as primary treatment device
Number of subjects: 3077
Study 33799302 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-CCE patients)
Number of subjects: 3077
Study 33799302 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall association of CCE with functional outcome
Number of subjects: 3077
Study 32571396 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based resistance exercise training
Number of subjects: 150
Study 32571396 — intervention group
Group type: EXPERIMENTAL
Intervention: Gym-based resistance exercise training
Number of subjects: 150
Study 32571396 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 150
Study 35537720 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 93
Study 35537720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 32236953 — intervention group
Group type: EXPERIMENTAL
Intervention: Licogliflozin (50 mg q.d.) with a 50% carbohydrate meal
Number of subjects: 24
Study 32236953 — intervention group
Group type: EXPERIMENTAL
Intervention: Licogliflozin (50 mg q.d.) with a 0% carbohydrate meal
Number of subjects: 24
Study 32236953 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium 6 g or calcium carbonate 1 g supplementation
Number of subjects: 24
Study 36477958 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Z350 XT
Number of subjects: 65
Study 36477958 — intervention group
Group type: EXPERIMENTAL
Intervention: FiltekTM Bulk‐fill
Number of subjects: 65
Study 36477958 — intervention group
Group type: COMPARATOR
Intervention: Bulk-fill resin
Number of subjects: 65
Study 36477958 — intervention group
Group type: COMPARATOR
Intervention: Conventional resin
Number of subjects: 65
Study 34560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily iTBS (600 pulses)
Number of subjects: 208
Study 34560319 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily iTBS (1200 pulses)
Number of subjects: 208
Study 34560319 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 208
Study 32893790 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble Continuous Positive Airway Pressure (bCPAP)
Number of subjects: 120
Study 32893790 — intervention group
Group type: COMPARATOR
Intervention: Nasal oxygen (Control)
Number of subjects: 120
Study 35153479 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination low-dose theophylline (100mg bd) and prednisone (5mg qd)
Number of subjects: 1487
Study 35153479 — intervention group
Group type: COMPARATOR
Intervention: Theophylline (100mg bd) and prednisone-matched placebo
Number of subjects: 1487
Study 35153479 — intervention group
Group type: COMPARATOR
Intervention: Double-matched placebo
Number of subjects: 1487
Study 34027703 — intervention group
Group type: EXPERIMENTAL
Intervention: LARA wheelchair (n = 11)
Number of subjects: 19
Study 34027703 — intervention group
Group type: COMPARATOR
Intervention: Conventional exercises (n = 8)
Number of subjects: 19
Study 33141883 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteomyelitis treatment
Number of subjects: 35
Study 33141883 — intervention group
Group type: COMPARATOR
Intervention: Osteomyelitis
Number of subjects: 35
Study 33141883 — intervention group
Group type: COMPARATOR
Intervention: Wound healing
Number of subjects: 35
Study 33141883 — intervention group
Group type: COMPARATOR
Intervention: Reulceration
Number of subjects: 35
Study 33141883 — intervention group
Group type: COMPARATOR
Intervention: Readmission for DFIs
Number of subjects: 35
Study 33141883 — intervention group
Group type: COMPARATOR
Intervention: Amputation
Number of subjects: 35
Study 32381522 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote electronic consent procedures
Number of subjects: 0
Study 32381522 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone consent procedures
Number of subjects: 0
Study 32381522 — intervention group
Group type: COMPARATOR
Intervention: In-person consent procedures
Number of subjects: 0
Study 35761268 — intervention group
Group type: EXPERIMENTAL
Intervention: sFlt-1
Number of subjects: 370
Study 35761268 — intervention group
Group type: EXPERIMENTAL
Intervention: sFlt-1/PIGF ratio (continuous)
Number of subjects: 370
Study 35761268 — intervention group
Group type: COMPARATOR
Intervention: PIGF
Number of subjects: 370
Study 35761268 — intervention group
Group type: COMPARATOR
Intervention: sFlt-1/PIGF ratio as cut-off at 38
Number of subjects: 370
Study 33839731 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min walk
Number of subjects: 40
Study 33839731 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 40
Study 35712800 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine quick release (BCQR) titrated from 0.8 mg to 1.6 mg to 3.2 mg (minimum dose 1.6 mg) for 4 weeks
Number of subjects: 80
Study 35712800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32789431 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiting time estimates provided to the intervention group
Number of subjects: 100
Study 32789431 — intervention group
Group type: COMPARATOR
Intervention: No waiting time estimates provided to the control group
Number of subjects: 100
Study 33978167 — intervention group
Group type: COMPARATOR
Intervention: 60 mg Fe with 0 mg folic acid
Number of subjects: 311
Study 33978167 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Fe with 0.4 mg folic acid
Number of subjects: 311
Study 33978167 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg Fe with 2.8 mg folic acid
Number of subjects: 311
Study 32895004 — intervention group
Group type: EXPERIMENTAL
Intervention: BP-SES
Number of subjects: 2337
Study 32895004 — intervention group
Group type: COMPARATOR
Intervention: DP-EES
Number of subjects: 2337
Study 35652772 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB‐IPACK block (30 mL bupivacaine 0.25%)
Number of subjects: 80
Study 35652772 — intervention group
Group type: COMPARATOR
Intervention: Adductor canal block (ACB) (20 mL bupivacaine 0.25%)
Number of subjects: 80
Study 35652772 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB‐IPACK block
Number of subjects: 80
Study 35652772 — intervention group
Group type: COMPARATOR
Intervention: ACB
Number of subjects: 80
Study 34730495 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg/day)
Number of subjects: 297
Study 34730495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 32524582 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal delivery
Number of subjects: 308
Study 32524582 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia
Number of subjects: 308
Study 32524582 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic oxytocin
Number of subjects: 308
Study 32524582 — intervention group
Group type: COMPARATOR
Intervention: Control group (planned cesarean section)
Number of subjects: 308
Study 36331326 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclisiran (284 mg administered on Days 1, 90, and every 6 months thereafter for 18 months)
Number of subjects: 3655
Study 36331326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3655
Study 36331326 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclisiran
Number of subjects: 3655
Study 32972900 — intervention group
Group type: EXPERIMENTAL
Intervention: Binary Disability Question (BDQ)
Number of subjects: 2807
Study 32972900 — intervention group
Group type: COMPARATOR
Intervention: Washington Group Short Set (WGSS1)
Number of subjects: 2807
Study 32972900 — intervention group
Group type: COMPARATOR
Intervention: Washington Group Short Set (WGSS2)
Number of subjects: 2807
Study 32284448 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot reflexology massage
Number of subjects: 90
Study 32284448 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple massage
Number of subjects: 90
Study 32284448 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study 35032224 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedal pump lymphatic technique
Number of subjects: 17
Study 35032224 — intervention group
Group type: COMPARATOR
Intervention: Passive supine recovery
Number of subjects: 17
Study 32032333 — intervention group
Group type: EXPERIMENTAL
Intervention: CoBRA audit tool
Number of subjects: 17956
Study 35946107 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum neurofilament light chain (sNfL)
Number of subjects: 0
Study 35946107 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower baseline volume of the transverse temporal gyrus
Number of subjects: 0
Study 34126308 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation Therapy for Anhedonia (BATA)
Number of subjects: 73
Study 34126308 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 73
Study 35863958 — intervention group
Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (VR) training
Number of subjects: 22
Study 35863958 — intervention group
Group type: COMPARATOR
Intervention: Technique Guide (TG) training
Number of subjects: 22
Study 34256199 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual transcranial direct current stimulation (dual tDCS) and modified constraint-induced movement therapy (mCIMT)
Number of subjects: 30
Study 34256199 — intervention group
Group type: COMPARATOR
Intervention: Sham dual tDCS and modified constraint-induced movement therapy (mCIMT)
Number of subjects: 30
Study 34256199 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual tDCS and mCIMT
Number of subjects: 30
Study 34256199 — intervention group
Group type: COMPARATOR
Intervention: Sham dual tDCS and mCIMT
Number of subjects: 30
Study 36435738 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant intravesical mitomycin C (MMC) at normothermia (control)
Number of subjects: 319
Study 36435738 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant intravesical mitomycin C (MMC) at 43 °C for 30 min
Number of subjects: 319
Study 36435738 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant intravesical mitomycin C (MMC) at 43 °C for 60 min
Number of subjects: 319
Study 33610174 — intervention group
Group type: EXPERIMENTAL
Intervention: BRIDGE program (new rehabilitation program)
Number of subjects: 357
Study 33610174 — intervention group
Group type: COMPARATOR
Intervention: Traditional rehabilitation program (control)
Number of subjects: 357
Study 36104267 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate 250 mg
Number of subjects: 4
Study 36104267 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate 500 mg
Number of subjects: 4
Study 36104267 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate 1000 mg
Number of subjects: 4
Study 36104267 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate 2000 mg
Number of subjects: 4
Study 36104267 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate (all doses)
Number of subjects: 4
Study 33059710 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 0
Study 33059710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33382916 — intervention group
Group type: EXPERIMENTAL
Intervention: LY2775240 (20 mg)
Number of subjects: 0
Study 33382916 — intervention group
Group type: COMPARATOR
Intervention: Apremilast (30 mg)
Number of subjects: 0
Study 32068366 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonsedation group
Number of subjects: 700
Study 32068366 — intervention group
Group type: COMPARATOR
Intervention: Sedation group
Number of subjects: 700
Study 36013087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam (20 mg after induction and 15 min before the end of surgery)
Number of subjects: 99
Study 36013087 — intervention group
Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 99
Study 36013087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam
Number of subjects: 99
Study 36013087 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 99
Study 36074392 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spine plane block (ESPB)
Number of subjects: 92
Study 36074392 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic block (BAL)
Number of subjects: 92
Study 33813948 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle change
Number of subjects: 515
Study 33813948 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 515
Study 33813948 — intervention group
Group type: EXPERIMENTAL
Intervention: Both options (intensive lifestyle change and metformin)
Number of subjects: 515
Study 33813948 — intervention group
Group type: COMPARATOR
Intervention: No intervention (usual care)
Number of subjects: 515
Study 33813948 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 515
Study 33813948 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients >60 years old
Number of subjects: 515
Study 33813948 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI
Number of subjects: 515
Study 32302018 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical balloon placement
Number of subjects: 300
Study 32302018 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine balloon placement
Number of subjects: 300
Study 35266189 — intervention group
Group type: EXPERIMENTAL
Intervention: Tät®II app for self-management of UUI and MUI
Number of subjects: 123
Study 34408675 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy (iCBT) plus treatment-as-usual (TAU)
Number of subjects: 81
Study 34408675 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) only
Number of subjects: 81
Study 35239196 — intervention group
Group type: EXPERIMENTAL
Intervention: Branded Guidelines (n = 26)
Number of subjects: 46
Study 35239196 — intervention group
Group type: COMPARATOR
Intervention: Unbranded Guidelines (n = 20)
Number of subjects: 46
Study 34097688 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender-neutral HPV vaccination (Arm A)
Number of subjects: 8022
Study 34097688 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls-only HPV vaccination (Arm B)
Number of subjects: 8022
Study 34097688 — intervention group
Group type: COMPARATOR
Intervention: No HPV vaccination (Arm C)
Number of subjects: 8022
Study 34817321 — intervention group
Group type: EXPERIMENTAL
Intervention: Danzhi Xiaoyao powder (DXP)
Number of subjects: 252
Study 34817321 — intervention group
Group type: COMPARATOR
Intervention: Danzhi Xiaoyao powder (DXP) + amlodipine
Number of subjects: 252
Study 33372439 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential current therapy (IFC), active therapy, three times per week for four weeks
Number of subjects: 62
Study 33372439 — intervention group
Group type: COMPARATOR
Intervention: Sham IFC stimulation (Control)
Number of subjects: 62
Study 35413872 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM-based text messages sent regularly for 48 weeks
Number of subjects: 518
Study 35413872 — intervention group
Group type: COMPARATOR
Intervention: Standard text message sent to parents in the control group in the first week
Number of subjects: 518
Study 33664568 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIDE intervention (social, physical, and cognitive domains supported by a facilitator over three sessions)
Number of subjects: 92
Study 33664568 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 92
Study 35482769 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (6-month randomized controlled trial)
Number of subjects: 131
Study 33509911 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme
Number of subjects: 3127
Study 34791009 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterols (PSs) 2 g/d for 28 days
Number of subjects: 42
Study 34791009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 33023785 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-weekly BTA treatment
Number of subjects: 263
Study 33023785 — intervention group
Group type: COMPARATOR
Intervention: 12-weekly BTA treatment
Number of subjects: 263
Study 34109872 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive interventions (specific details not provided)
Number of subjects: 9
Study 33619835 — intervention group
Group type: EXPERIMENTAL
Intervention: α-galactosidase (1200 GaIU/meal)
Number of subjects: 20
Study 33619835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 35688164 — intervention group
Group type: EXPERIMENTAL
Intervention: tixagevimab–cilgavimab 600 mg (two consecutive 3 mL intramuscular injections, 300 mg tixagevimab and 300 mg cilgavimab)
Number of subjects: 910
Study 35688164 — intervention group
Group type: EXPERIMENTAL
Intervention: tixagevimab–cilgavimab 600 mg
Number of subjects: 910
Study 33845880 — intervention group
Group type: EXPERIMENTAL
Intervention: GPR + a smartphone app
Number of subjects: 60
Study 33845880 — intervention group
Group type: EXPERIMENTAL
Intervention: GPR alone
Number of subjects: 60
Study 33845880 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 32652133 — intervention group
Group type: EXPERIMENTAL
Intervention: Best practices plus financial incentives
Number of subjects: 60
Study 32652133 — intervention group
Group type: COMPARATOR
Intervention: Best practices alone
Number of subjects: 60
Study 35565929 — intervention group
Group type: EXPERIMENTAL
Intervention: Iso-caloric high-fat diet (HFD)
Number of subjects: 15
Study 35565929 — intervention group
Group type: COMPARATOR
Intervention: Iso-caloric high-carbohydrate diet (HCD)
Number of subjects: 15
Study 32957335 — intervention group
Group type: EXPERIMENTAL
Intervention: Jaw Opening Exercise (JOE)
Number of subjects: 30
Study 32957335 — intervention group
Group type: COMPARATOR
Intervention: Head Lift Exercise (HLE)
Number of subjects: 30
Study 34980609 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (McGrath Mac videolaryngoscope)
Number of subjects: 256
Study 34980609 — intervention group
Group type: COMPARATOR
Intervention: No-video group
Number of subjects: 256
Study 34980609 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group
Number of subjects: 256
Study 34980609 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 256
Study 33271319 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dydrogesterone
Number of subjects: 134
Study 33271319 — intervention group
Group type: COMPARATOR
Intervention: Micronized vaginal progesterone (MVP) gel
Number of subjects: 134
Study 32310162 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE) training
Number of subjects: 30
Study 32310162 — intervention group
Group type: COMPARATOR
Intervention: Stretch training (Control)
Number of subjects: 30
Study 36200919 — intervention group
Group type: EXPERIMENTAL
Intervention: OPF (OpalescencePF‐20%)
Number of subjects: 10
Study 36200919 — intervention group
Group type: EXPERIMENTAL
Intervention: WPC (Whiteness Perfect‐22%)
Number of subjects: 10